Megan Brown, PA
Payments from drug & device makers
What this record shows
10 manufacturers reported payments, led by Axonics, Inc. at 56.6% of the total. Reporting peaked in 2024 at $1,852 and has fallen 95.9% since, to $77 in 2025. Among surgical clinicians in ID with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 54 payments — averaging $57.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axonics, Inc.$2K
- Intuitive Surgical$1K
- Laborie Medical Technologies Corp.$64
- BD$50
- AbbVie$45
- Johnson & Johnson$38
- plus $102 from 4 others
What the payments were for
- Travel & lodging$1,28941%
- Food & beverage$1,82359%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axonics, Inc. | 15 | $1,763 |
| Intuitive Surgical | 29 | $1,051 |
| Laborie Medical Technologies Corp. | 2 | $64 |
| BD | 1 | $50 |
| AbbVie | 2 | $45 |
| Johnson & Johnson | 1 | $38 |
| Medtronic | 1 | $33 |
| 180 Medical, Inc. | 1 | $29 |
| Silk Road Medical, Inc. | 1 | $27 |
| Atricure, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Axonics$1,330
How this compares
$3,113 in reported general payments places this provider in the 90th percentile of 78 surgical providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 53 | $46,916 |
| GemtesaVibegron | 14 | $13,153 |
| Estradiol | 198 | $11,716 |
| EliquisApixaban | 34 | $8,923 |
| Trospium Chloride ErTrospium Chloride | 48 | $5,926 |
| Cephalexin | 11 | $146 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $140 |
| Celecoxib | 62 | $101 |
| Oxycodone Hcl | 37 | $73 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 21 | $46 |
| Tramadol Hcl | 17 | $21 |
Paid to pharmacies, not to this prescriber.
Other surgical in Boise
- Michael NieraethBoise$5K
- Jeffrey GriggsBoise$3K
- Andrew SwensonBoise$2K
- Rilee MickelsenBoise$1K
- Anna HoskinsBoise$1K
- Joshua FisherBoise$1K
- Mitchell BlumeBoise$728
- Scott BurnettBoise$657
- Annie CampbellBoise$447
- Beau WalkerBoise$403
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.